Calithera Biosciences, Inc.
CONJOINT THERAPY WITH GLUTAMINASE INHIBITORS
Last updated:
Abstract:
The invention relates to methods of treating cancer using novel heterocyclic glutaminase inhibitor compounds conjointly with a PD1 or PD-L1 inhibitor.
Status:
Application
Type:
Utility
Filling date:
1 Nov 2018
Issue date:
17 Jun 2021